Located at the Daresbury site of the renowned UK-based Science and Technology Facilities Council (STFC), with $300+ million invested to date in ...
InvestorsHub on MSN
Lixte Biotechnology shares slide following purchase of UK-based Liora
Lixte Biotechnology Holdings Inc. (NASDAQ:LIXT) saw its stock drop 11.5% on Tuesday after the company announced the ...
TipRanks on MSN
Lixte Biotechnology acquires Liora’s proton therapy platform
LIXTE Biotechnology (LIXT) announced it has completed the acquisition of Liora Technologies Europe, a UK-based company pioneering electronically ...
NEW: @hopkinskimmel at Sibley receives $40M to expand pediatric proton therapy. The new center will unite Hopkins, ...
Proton Therapy reduces the risk of a second cancer diagnosis by 69% versus other forms of radiation treatment according to a paper recently released by a team from Stanford University. The study ...
Please provide your email address to receive an email when new articles are posted on . In the first study, Nogueira and colleagues examined the overall patterns of use of proton beam therapy ...
Last week, we told you about Oklahoma City’s Proton Center stopping treatment for patients after its machine went down.
LITTLETON, Mass.--(BUSINESS WIRE)--Mevion Medical Systems, the leading provider of compact proton therapy systems for use in radiation treatment for cancer patients, today introduced its new product, ...
Australia was promised world-class proton beam therapy nearly a decade ago. A life-saving technology that precisely targets ...
A 16-month-old boy is waiting to find out if he can receive lifesaving surgery on the other side of the world after being diagnosed with a rare and aggressive cancer.
The esophagus is the organ in the throat that moves food from the mouth to the stomach. Esophageal cancers make up approximately 1% of cancer diagnoses in the U.S., making them rare. Because many ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results